InMode (INMD) Net Shares Issued and Repurchased (2020 - 2026)
InMode (INMD) posted quarterly Net Shares Issued and Repurchased of -$31.2 million for Q1 2026, up 68.75% year-on-year from -$18.5 million in Q1 2025, and down 13.67% on a QoQ basis from -$27.5 million in Q2 2025.
InMode (INMD) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends
InMode (INMD) has reported Net Shares Issued and Repurchased for 6 consecutive years, with -$31.2 million the latest figure, recorded in Q1 2026.
- Quarterly Net Shares Issued and Repurchased rose 68.75% year-over-year to -$31.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58.7 million (up 84.76% YoY) and the FY2025 annual result came in at -$127.4 million, up 55.34% from the prior year.
- Net Shares Issued and Repurchased declined to -$31.2 million in Q1 2026 per INMD's latest filing, from -$27.5 million in the prior quarter.
- Over the last five years, Net Shares Issued and Repurchased for INMD reached as high as -$27.5 million in Q2 2025 and fell as low as -$119.8 million in Q4 2024.
- A 4-year average of -$69.5 million and a median of -$76.6 million in 2024 frame the typical range for Net Shares Issued and Repurchased.
- Annual changes were most pronounced in 2022 — Net Shares Issued and Repurchased tumbled 4834.84% — and 2025, when it jumped 69.11%.
- Year by year, Net Shares Issued and Repurchased stood at -$42.6 million in 2022, then tumbled by 181.09% to -$119.8 million in 2024, then soared by 77.07% to -$27.5 million in 2025, then slipped by 13.67% to -$31.2 million in 2026.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered -$31.2 million, -$27.5 million, and -$100.0 million for Q1 2026, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | -31.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.24 Mn |
| Mar 31, 2026 | -31.24 Mn |
| Jun 30, 2025 | -27.48 Mn |
| Jun 30, 2025 | -27.48 Mn |
| Mar 31, 2025 | -99.96 Mn |
| Mar 31, 2025 | -99.96 Mn |
| Dec 31, 2024 | -119.85 Mn |
| Dec 31, 2024 | -119.85 Mn |
| Sep 30, 2024 | -76.56 Mn |
| Sep 30, 2024 | -76.56 Mn |
| Jun 30, 2024 | -88.98 Mn |
| Jun 30, 2024 | -88.98 Mn |
| Mar 31, 2022 | -42.64 Mn |
| Mar 31, 2022 | -42.64 Mn |
| Dec 31, 2021 | -23.44 Mn |
| Dec 31, 2021 | -23.44 Mn |
| Jun 30, 2021 | -11.06 Mn |
| Jun 30, 2021 | -11.06 Mn |
| Mar 31, 2021 | -864,000.00 |
| Mar 31, 2021 | -864,000.00 |